▶ 調査レポート

トロンビンのグローバル市場2022年

• 英文タイトル:Global Thrombin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Thrombin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028「トロンビンのグローバル市場2022年」(市場規模、市場予測)調査レポートです。• レポートコード:GIR-23F3946
• 出版社/出版日:GlobalInfoResearch / 2023年2月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Thrombin Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社(香港)の最新の調査によると、世界のトロンビンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

トロンビン市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次を対象にします。
・紛末状、溶液状、パッド状、スプレーキット、その他

アプリケーション別セグメントは次のように区分されます。
・病院、診療所、学術研究機関

世界のトロンビン市場の主要なマーケットプレーヤーは以下のとおりです。
・Takeda、Bayer、CSL、Grifols、GE Healthcare、Hualan Biological、Haematologic Technologies Inc.、Pfizer、Octapharma、Omrix Biopharmaceuticals Ltd.、Shanghai RAAS

地域別セグメントは次の地域・国を対象にします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

***** 目次(一部) *****

・市場概要
- トロンビンの概要
- タイプ別分析(2017年vs2021年vs2028年):紛末状、溶液状、パッド状、スプレーキット、その他
- アプリケーション別分析(2017年vs2021年vs2028年):病院、診療所、学術研究機関
- 世界のトロンビン市場規模・予測
- 世界のトロンビン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Takeda、Bayer、CSL、Grifols、GE Healthcare、Hualan Biological、Haematologic Technologies Inc.、Pfizer、Octapharma、Omrix Biopharmaceuticals Ltd.、Shanghai RAAS
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:紛末状、溶液状、パッド状、スプレーキット、その他
・アプリケーション別分析2017年-2028年:病院、診療所、学術研究機関
・トロンビンの北米市場分析
- トロンビンの北米市場:タイプ別市場規模2017年-2028年
- トロンビンの北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・トロンビンのヨーロッパ市場分析
- :トロンビンのヨーロッパ市場:タイプ別市場規模2017年-2028年
- :トロンビンのヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・トロンビンのアジア太平洋市場分析
- トロンビンのアジア太平洋市場:タイプ別市場規模2017年-2028年
- トロンビンのアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・トロンビンの南米市場分析
- トロンビンの南米市場:タイプ別市場規模2017年-2028年
- トロンビンの南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・トロンビンの中東・アフリカ市場分析
- トロンビンの中東・アフリカ市場:タイプ別市場規模2017年-2028年
- トロンビンの中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Thrombin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Thrombin market size is estimated to be worth US$ 581.3 million in 2021 and is forecast to a readjusted size of USD 715.7 million by 2028 with a CAGR of 3.0% during review period. Hospitals accounting for % of the Thrombin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder Form segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Thrombin include Takeda, Bayer, CSL, Grifols, and GE Healthcare, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Thrombin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Market segment by Application can be divided into
Hospitals
Diagnostics & Clinics
Academic and Research Institute
The key market players for global Thrombin market are listed below:
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Thrombin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Thrombin, with price, sales, revenue and global market share of Thrombin from 2019 to 2022.
Chapter 3, the Thrombin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Thrombin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Thrombin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Thrombin.
Chapter 13, 14, and 15, to describe Thrombin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Thrombin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Thrombin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder Form
1.2.3 Solution Form
1.2.4 Pad Form
1.2.5 Spray Kits
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Thrombin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Thrombin Market Size & Forecast
1.4.1 Global Thrombin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Thrombin Sales in Volume (2017-2028)
1.4.3 Global Thrombin Price (2017-2028)
1.5 Global Thrombin Production Capacity Analysis
1.5.1 Global Thrombin Total Production Capacity (2017-2028)
1.5.2 Global Thrombin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Thrombin Market Drivers
1.6.2 Thrombin Market Restraints
1.6.3 Thrombin Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Thrombin Product and Services
2.1.4 Takeda Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Thrombin Product and Services
2.2.4 Bayer Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Thrombin Product and Services
2.3.4 CSL Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Thrombin Product and Services
2.4.4 Grifols Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Thrombin Product and Services
2.5.4 GE Healthcare Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hualan Biological
2.6.1 Hualan Biological Details
2.6.2 Hualan Biological Major Business
2.6.3 Hualan Biological Thrombin Product and Services
2.6.4 Hualan Biological Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Haematologic Technologies Inc.
2.7.1 Haematologic Technologies Inc. Details
2.7.2 Haematologic Technologies Inc. Major Business
2.7.3 Haematologic Technologies Inc. Thrombin Product and Services
2.7.4 Haematologic Technologies Inc. Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Thrombin Product and Services
2.8.4 Pfizer Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Octapharma
2.9.1 Octapharma Details
2.9.2 Octapharma Major Business
2.9.3 Octapharma Thrombin Product and Services
2.9.4 Octapharma Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Omrix Biopharmaceuticals Ltd.
2.10.1 Omrix Biopharmaceuticals Ltd. Details
2.10.2 Omrix Biopharmaceuticals Ltd. Major Business
2.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Product and Services
2.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shanghai RAAS
2.11.1 Shanghai RAAS Details
2.11.2 Shanghai RAAS Major Business
2.11.3 Shanghai RAAS Thrombin Product and Services
2.11.4 Shanghai RAAS Thrombin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Thrombin Breakdown Data by Manufacturer
3.1 Global Thrombin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Thrombin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Thrombin
3.4 Market Concentration Rate
3.4.1 Top 3 Thrombin Manufacturer Market Share in 2021
3.4.2 Top 6 Thrombin Manufacturer Market Share in 2021
3.5 Global Thrombin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Thrombin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Thrombin Market Size by Region
4.1.1 Global Thrombin Sales in Volume by Region (2017-2028)
4.1.2 Global Thrombin Revenue by Region (2017-2028)
4.2 North America Thrombin Revenue (2017-2028)
4.3 Europe Thrombin Revenue (2017-2028)
4.4 Asia-Pacific Thrombin Revenue (2017-2028)
4.5 South America Thrombin Revenue (2017-2028)
4.6 Middle East and Africa Thrombin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Thrombin Sales in Volume by Type (2017-2028)
5.2 Global Thrombin Revenue by Type (2017-2028)
5.3 Global Thrombin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Thrombin Sales in Volume by Application (2017-2028)
6.2 Global Thrombin Revenue by Application (2017-2028)
6.3 Global Thrombin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Thrombin Sales by Type (2017-2028)
7.2 North America Thrombin Sales by Application (2017-2028)
7.3 North America Thrombin Market Size by Country
7.3.1 North America Thrombin Sales in Volume by Country (2017-2028)
7.3.2 North America Thrombin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Thrombin Sales by Type (2017-2028)
8.2 Europe Thrombin Sales by Application (2017-2028)
8.3 Europe Thrombin Market Size by Country
8.3.1 Europe Thrombin Sales in Volume by Country (2017-2028)
8.3.2 Europe Thrombin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Thrombin Sales by Type (2017-2028)
9.2 Asia-Pacific Thrombin Sales by Application (2017-2028)
9.3 Asia-Pacific Thrombin Market Size by Region
9.3.1 Asia-Pacific Thrombin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Thrombin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Thrombin Sales by Type (2017-2028)
10.2 South America Thrombin Sales by Application (2017-2028)
10.3 South America Thrombin Market Size by Country
10.3.1 South America Thrombin Sales in Volume by Country (2017-2028)
10.3.2 South America Thrombin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Thrombin Sales by Type (2017-2028)
11.2 Middle East & Africa Thrombin Sales by Application (2017-2028)
11.3 Middle East & Africa Thrombin Market Size by Country
11.3.1 Middle East & Africa Thrombin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Thrombin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Thrombin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Thrombin
12.3 Thrombin Production Process
12.4 Thrombin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Thrombin Typical Distributors
13.3 Thrombin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Thrombin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Thrombin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Thrombin Product and Services
Table 6. Takeda Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Thrombin Product and Services
Table 10. Bayer Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Thrombin Product and Services
Table 14. CSL Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Grifols Basic Information, Manufacturing Base and Competitors
Table 16. Grifols Major Business
Table 17. Grifols Thrombin Product and Services
Table 18. Grifols Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. GE Healthcare Major Business
Table 21. GE Healthcare Thrombin Product and Services
Table 22. GE Healthcare Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 24. Hualan Biological Major Business
Table 25. Hualan Biological Thrombin Product and Services
Table 26. Hualan Biological Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Haematologic Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Haematologic Technologies Inc. Major Business
Table 29. Haematologic Technologies Inc. Thrombin Product and Services
Table 30. Haematologic Technologies Inc. Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Thrombin Product and Services
Table 34. Pfizer Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Octapharma Basic Information, Manufacturing Base and Competitors
Table 36. Octapharma Major Business
Table 37. Octapharma Thrombin Product and Services
Table 38. Octapharma Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Omrix Biopharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Omrix Biopharmaceuticals Ltd. Major Business
Table 41. Omrix Biopharmaceuticals Ltd. Thrombin Product and Services
Table 42. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Thrombin Product and Services
Table 46. Shanghai RAAS Thrombin Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Thrombin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 48. Global Thrombin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Thrombin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Thrombin Production Capacity by Company, (MT): 2020 VS 2021
Table 51. Head Office and Thrombin Production Site of Key Manufacturer
Table 52. Thrombin New Entrant and Capacity Expansion Plans
Table 53. Thrombin Mergers & Acquisitions in the Past Five Years
Table 54. Global Thrombin Sales by Region (2017-2022) & (MT)
Table 55. Global Thrombin Sales by Region (2023-2028) & (MT)
Table 56. Global Thrombin Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Thrombin Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Thrombin Sales by Type (2017-2022) & (MT)
Table 59. Global Thrombin Sales by Type (2023-2028) & (MT)
Table 60. Global Thrombin Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Thrombin Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Thrombin Price by Type (2017-2022) & (USD/Kg)
Table 63. Global Thrombin Price by Type (2023-2028) & (USD/Kg)
Table 64. Global Thrombin Sales by Application (2017-2022) & (MT)
Table 65. Global Thrombin Sales by Application (2023-2028) & (MT)
Table 66. Global Thrombin Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Thrombin Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Thrombin Price by Application (2017-2022) & (USD/Kg)
Table 69. Global Thrombin Price by Application (2023-2028) & (USD/Kg)
Table 70. North America Thrombin Sales by Country (2017-2022) & (MT)
Table 71. North America Thrombin Sales by Country (2023-2028) & (MT)
Table 72. North America Thrombin Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Thrombin Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Thrombin Sales by Type (2017-2022) & (MT)
Table 75. North America Thrombin Sales by Type (2023-2028) & (MT)
Table 76. North America Thrombin Sales by Application (2017-2022) & (MT)
Table 77. North America Thrombin Sales by Application (2023-2028) & (MT)
Table 78. Europe Thrombin Sales by Country (2017-2022) & (MT)
Table 79. Europe Thrombin Sales by Country (2023-2028) & (MT)
Table 80. Europe Thrombin Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Thrombin Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Thrombin Sales by Type (2017-2022) & (MT)
Table 83. Europe Thrombin Sales by Type (2023-2028) & (MT)
Table 84. Europe Thrombin Sales by Application (2017-2022) & (MT)
Table 85. Europe Thrombin Sales by Application (2023-2028) & (MT)
Table 86. Asia-Pacific Thrombin Sales by Region (2017-2022) & (MT)
Table 87. Asia-Pacific Thrombin Sales by Region (2023-2028) & (MT)
Table 88. Asia-Pacific Thrombin Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Thrombin Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Thrombin Sales by Type (2017-2022) & (MT)
Table 91. Asia-Pacific Thrombin Sales by Type (2023-2028) & (MT)
Table 92. Asia-Pacific Thrombin Sales by Application (2017-2022) & (MT)
Table 93. Asia-Pacific Thrombin Sales by Application (2023-2028) & (MT)
Table 94. South America Thrombin Sales by Country (2017-2022) & (MT)
Table 95. South America Thrombin Sales by Country (2023-2028) & (MT)
Table 96. South America Thrombin Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Thrombin Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Thrombin Sales by Type (2017-2022) & (MT)
Table 99. South America Thrombin Sales by Type (2023-2028) & (MT)
Table 100. South America Thrombin Sales by Application (2017-2022) & (MT)
Table 101. South America Thrombin Sales by Application (2023-2028) & (MT)
Table 102. Middle East & Africa Thrombin Sales by Region (2017-2022) & (MT)
Table 103. Middle East & Africa Thrombin Sales by Region (2023-2028) & (MT)
Table 104. Middle East & Africa Thrombin Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Thrombin Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Thrombin Sales by Type (2017-2022) & (MT)
Table 107. Middle East & Africa Thrombin Sales by Type (2023-2028) & (MT)
Table 108. Middle East & Africa Thrombin Sales by Application (2017-2022) & (MT)
Table 109. Middle East & Africa Thrombin Sales by Application (2023-2028) & (MT)
Table 110. Thrombin Raw Material
Table 111. Key Manufacturers of Thrombin Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Thrombin Typical Distributors
Table 115. Thrombin Typical Customers
List of Figures
Figure 1. Thrombin Picture
Figure 2. Global Thrombin Revenue Market Share by Type in 2021
Figure 3. Powder Form
Figure 4. Solution Form
Figure 5. Pad Form
Figure 6. Spray Kits
Figure 7. Others
Figure 8. Global Thrombin Revenue Market Share by Application in 2021
Figure 9. Hospitals
Figure 10. Diagnostics & Clinics
Figure 11. Academic and Research Institute
Figure 12. Global Thrombin Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 13. Global Thrombin Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Thrombin Sales (2017-2028) & (MT)
Figure 15. Global Thrombin Price (2017-2028) & (USD/Kg)
Figure 16. Global Thrombin Production Capacity (2017-2028) & (MT)
Figure 17. Global Thrombin Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Thrombin Market Drivers
Figure 19. Thrombin Market Restraints
Figure 20. Thrombin Market Trends
Figure 21. Global Thrombin Sales Market Share by Manufacturer in 2021
Figure 22. Global Thrombin Revenue Market Share by Manufacturer in 2021
Figure 23. Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Thrombin Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Thrombin Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Thrombin Sales Market Share by Region (2017-2028)
Figure 27. Global Thrombin Revenue Market Share by Region (2017-2028)
Figure 28. North America Thrombin Revenue (2017-2028) & (USD Million)
Figure 29. Europe Thrombin Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Thrombin Revenue (2017-2028) & (USD Million)
Figure 31. South America Thrombin Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Thrombin Revenue (2017-2028) & (USD Million)
Figure 33. Global Thrombin Sales Market Share by Type (2017-2028)
Figure 34. Global Thrombin Revenue Market Share by Type (2017-2028)
Figure 35. Global Thrombin Price by Type (2017-2028) & (USD/Kg)
Figure 36. Global Thrombin Sales Market Share by Application (2017-2028)
Figure 37. Global Thrombin Revenue Market Share by Application (2017-2028)
Figure 38. Global Thrombin Price by Application (2017-2028) & (USD/Kg)
Figure 39. North America Thrombin Sales Market Share by Type (2017-2028)
Figure 40. North America Thrombin Sales Market Share by Application (2017-2028)
Figure 41. North America Thrombin Sales Market Share by Country (2017-2028)
Figure 42. North America Thrombin Revenue Market Share by Country (2017-2028)
Figure 43. United States Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Thrombin Sales Market Share by Type (2017-2028)
Figure 47. Europe Thrombin Sales Market Share by Application (2017-2028)
Figure 48. Europe Thrombin Sales Market Share by Country (2017-2028)
Figure 49. Europe Thrombin Revenue Market Share by Country (2017-2028)
Figure 50. Germany Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Thrombin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Thrombin Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Thrombin Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Thrombin Revenue Market Share by Region (2017-2028)
Figure 59. China Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Thrombin Sales Market Share by Type (2017-2028)
Figure 66. South America Thrombin Sales Market Share by Application (2017-2028)
Figure 67. South America Thrombin Sales Market Share by Country (2017-2028)
Figure 68. South America Thrombin Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Thrombin Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Thrombin Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Thrombin Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Thrombin Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Thrombin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Thrombin in 2021
Figure 80. Manufacturing Process Analysis of Thrombin
Figure 81. Thrombin Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source